Dose-dense sequential chemotherapy with epirubicin (E), paclitaxel (T) and cyclophosphamide (C) (ETC) in comparison to conventional dosed chemotherapy in high-risk breast cancer patients (4+ LN). Mature results of an AGO-trial - Moebus, V; Lueck, H J; Thomssen, C; Kuhn, W; Kurbacher, C; Nitz, U; Kreienberg, R; Untch, M; Jackisch, C; Schneeweiss, A; Huober, J; du Bois, A (San Antonio Breast Cancer Symposium: Abstract, 2006)